Focus on risk factors for fungal infections in ICU patients

Minerva Anestesiologica

Volumn 68, Issue 4, 2002, Pages 269-272

  Tufano, R ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Dipartimento di Scienze Chirurgiche   (Italy)

Author keywords

Intensive care units; Mycoses, diagnosis; Mycoses, prevention and control; Mycoses, therapy

Indexed keywords

BURN; DISEASE SEVERITY; FUNGAL COLONIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDWELLING CATHETER; INTENSIVE CARE UNIT; MYCOSIS; PARENTERAL NUTRITION; REVIEW; RISK FACTOR; CANDIDIASIS; INTENSIVE CARE; MICROBIOLOGY;

CANDIDIASIS; HUMANS; INTENSIVE CARE; MYCOSES; RISK FACTORS;

EID: 0036548832     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Archibald LK, Philips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates for inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211-5.
2. Vincet JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoine MH et al. The prevalence of nosocomial infection in intensive care units in Europe (EPIC). JAMA 1995;274:639-44.
3. Heslet L, Mosgaard F, Tvede M. Fungal infection in critically ill patients. In: Vincent JL, editor. 2001 Year-book of Intensive Care and Emergency Medicine. New York: Spinger, 2001:162-74.
4. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A mached case-control study. Arch Intern Med 1989;149:2349-53.
5. Voss A, le Noble JLM, Verduyn Lunel FM, Foudraine NA, Meis JFGM. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997;25:8-11.
6. Pfaller MA, Jones RN, Doern GV, Sader HS, Messer A, Houston A et al. Bloodstream infections due to Candida species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998. Antimicrob Ag Chemother 2000;44:747-51.
7. Lipsett PA. Fungal infections in critically ill surgical patients. In: Vincent JL, editor. 2000 Yearbook of Intensive Care and Emergency Medicine. New York: Spinger, 2000:135-43.
8. Krause W, Matheis H, Wulf K. Fungemia and funguria after oral administration of Candida albicans. Lancet 1969;1:598-9.
9. Petri MG, Koning J, Moecke HP, Gramm HJ, Barkow H, Kujath P et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Int Care Med 1997;23:317-25.
10. Martino P, Girmenia C, Micozzi A, Raccah R, Gentile G, Venditti M et al. Fungemia in patients with leucemia. Am J Med Sci 1993;306:225-32.
11. Dean DA, Burchard KW. Surgical perspectives on invasive Candida infections. World J Surg 1998;22:127-34.
12. Vincent JL, Anaissie E, Bruining H, Demajo W, El-Ebiary M, Haber J et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998;24:206-16.
13. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;220:751-8.
14. Solomkin JS. Epidemiology, risk factors, and diagnosis of severe fungine infections. Minerva Anestesiol 2001;66(Suppl 1):67-8.